Skip to main content
PMC home page
Gut logoLink to Gut
. 1984 Nov;25(11):1291–1295. doi: 10.1136/gut.25.11.1291

Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.

B Limberg, B Kommerell
PMCID: PMC1432315  PMID: 6149982

Abstract

The purpose of our study was to evaluate the effect of somatostatin (500 microgram/h intravenously) upon insulin, c-peptide, glucagon and plasma amino acids concentrations in patients with and without cirrhosis of the liver. The typical plasma amino acid pattern in cirrhosis is characterised by increased concentrations of the aromatic amino acids and decreased concentrations of the branched chain amino acids and of alanine and glycine. After administration of somatostatin insulin, c-peptide and glucagon concentrations decreased and those of the branched chain amino acids in both groups increased; in addition in patients with cirrhosis the plasma concentrations of threonine, serine, glycine, alanine, lysine, and arginine increased also. Infusion of somatostatin plus insulin in patients with cirrhosis succeeded in preventing the increase in the branched chain amino acid concentrations, while the infusion of somatostatin plus glucagon decreased threonine, serine, glycine, alinine, phenylalanine, tyrosine, lysine and arginine concentrations. It is therefore suggested that the effect of somatostatin on the plasma amino acids may be because of the reduction of insulin and glucagon concentrations; however, other effects of somatostatin cannot be excluded at present.

Full text

PDF
1291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger M., Zimmermann-Telschow H., Berchtold P., Drost H., Müller W. A., Gries F. A., Zimmermann H. Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism. 1978 Jul;27(7):793–799. doi: 10.1016/0026-0495(78)90214-7. [DOI] [PubMed] [Google Scholar]
  2. Carlsten A., Hallgren B., Jagenburg R., Svanborg A., Werkö L. Amino acids and free fatty acids in plasma in diabetes. I. The effect of insulin on the arterial levels. Acta Med Scand. 1966 Mar;179(3):361–370. doi: 10.1111/j.0954-6820.1966.tb05471.x. [DOI] [PubMed] [Google Scholar]
  3. Cherrington A. D., Lacy W. W., Chiasson J. L. Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest. 1978 Sep;62(3):664–677. doi: 10.1172/JCI109174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Faber O. K., Kehlet H., Madsbad S., Binder C. Kinetics of human C-peptide in man. Diabetes. 1978;27 (Suppl 1):207–209. doi: 10.2337/diab.27.1.s207. [DOI] [PubMed] [Google Scholar]
  5. Fischer J. E., Rosen H. M., Ebeid A. M., James J. H., Keane J. M., Soeters P. B. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 1976 Jul;80(1):77–91. [PubMed] [Google Scholar]
  6. Ganda O. P., Ruderman N. B. Muscle nitrogen metabolism in chronic hepatic insufficiency. Metabolism. 1976 Apr;25(4):427–435. doi: 10.1016/0026-0495(76)90075-5. [DOI] [PubMed] [Google Scholar]
  7. Haley C. J., Harper A. E. Glucagon stimulation of phenylalanine metabolism. The effects of acute and chronic glucagon treatment. Metabolism. 1982 Jun;31(6):524–532. doi: 10.1016/0026-0495(82)90089-0. [DOI] [PubMed] [Google Scholar]
  8. Hanna A. K., Zinman B., Nakhooda A. F., Minuk H. L., Stokes E. F., Albisser A. M., Leibel B. S., Marliss E. B. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man. Metabolism. 1980 Apr;29(4):321–332. doi: 10.1016/0026-0495(80)90005-0. [DOI] [PubMed] [Google Scholar]
  9. Heding L. G. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975 Dec;11(6):541–548. doi: 10.1007/BF01222104. [DOI] [PubMed] [Google Scholar]
  10. James J. H., Ziparo V., Jeppsson B., Fischer J. E. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet. 1979 Oct 13;2(8146):772–775. doi: 10.1016/s0140-6736(79)92119-6. [DOI] [PubMed] [Google Scholar]
  11. Johnson D. G., Alberti K. G., Faber O. K., Binder C. Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion? Lancet. 1977 Jan 1;1(8001):10–13. doi: 10.1016/s0140-6736(77)91652-x. [DOI] [PubMed] [Google Scholar]
  12. Katz A. I., Lindheimer M. D., Mako M. E., Rubenstein A. H. Peripheral metabolism of insulin, proinsulin, and C-peptide in the pregnant rat. J Clin Invest. 1975 Dec;56(6):1608–1614. doi: 10.1172/JCI108243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Koerker D. J., Ruch W., Chideckel E., Palmer J., Goodner C. J., Ensinck J., Gale C. C. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science. 1974 Apr 26;184(4135):482–484. doi: 10.1126/science.184.4135.482. [DOI] [PubMed] [Google Scholar]
  14. Lefebvre P. J., Luyckx A. S. Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism. 1975 Oct;24(10):1169–1176. doi: 10.1016/0026-0495(75)90153-5. [DOI] [PubMed] [Google Scholar]
  15. Liljenquist J. E., Lewis S. B., Cherrington A. D., Sinclair-Smith B. C., Lacy W. W. Effects of pharmacologic hyperglucagonemia on plasma amino acid concentrations in normal and diabetic man. Metabolism. 1981 Dec;30(12):1195–1199. doi: 10.1016/0026-0495(81)90041-x. [DOI] [PubMed] [Google Scholar]
  16. Mallinson C. N., Bloom S. R., Warin A. P., Salmon P. R., Cox B. A glucagonoma syndrome. Lancet. 1974 Jul 6;2(7871):1–5. doi: 10.1016/s0140-6736(74)91343-9. [DOI] [PubMed] [Google Scholar]
  17. Marchesini G., Forlani G., Zoli M., Angiolini A., Scolari M. P., Bianchi F. B., Pisi E. Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy. Dig Dis Sci. 1979 Aug;24(8):594–601. doi: 10.1007/BF01333703. [DOI] [PubMed] [Google Scholar]
  18. Marchesini G., Zoli M., Angiolini A., Dondi C., Bianchi F. B., Pisi E. Muscle protein breakdown in liver cirrhosis and the role of altered carbohydrate metabolism. Hepatology. 1981 Jul-Aug;1(4):294–299. doi: 10.1002/hep.1840010403. [DOI] [PubMed] [Google Scholar]
  19. Morgan M. Y., Marshall A. W., Milsom J. P., Sherlock S. Plasma amino-acid patterns in liver disease. Gut. 1982 May;23(5):362–370. doi: 10.1136/gut.23.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Munro H. N., Fernstrom J. D., Wurtman R. J. Insulin, plasma aminoacid imbalance, and hepatic coma. Lancet. 1975 Mar 29;1(7909):722–724. doi: 10.1016/s0140-6736(75)91632-3. [DOI] [PubMed] [Google Scholar]
  21. Riggio O., Merli M., Cangiano C., Capocaccia R., Cascino A., Lala A., Leonetti F., Mauceri M., Pepe M., Rossi Fanelli F. Glucose intolerance in liver cirrhosis. Metabolism. 1982 Jun;31(6):627–634. doi: 10.1016/0026-0495(82)90103-2. [DOI] [PubMed] [Google Scholar]
  22. Rosen H. M., Yoshimura N., Hodgman J. M., Fischer J. E. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology. 1977 Mar;72(3):483–487. [PubMed] [Google Scholar]
  23. Sherwin R. S., Fisher M., Bessoff J., Snyder N., Hendler R., Conn H. O., Felig P. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon. Gastroenterology. 1978 Jun;74(6):1224–1228. [PubMed] [Google Scholar]
  24. Sherwin R., Joshi P., Hendler R., Felig P., Conn H. O. Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting. N Engl J Med. 1974 Jan 31;290(5):239–242. doi: 10.1056/NEJM197401312900502. [DOI] [PubMed] [Google Scholar]
  25. Smith-Laing G., Sherlock S., Faber O. K. Effects of spontaneous portal-systemic shunting on insulin metabolism. Gastroenterology. 1979 Apr;76(4):685–690. [PubMed] [Google Scholar]
  26. Soeters P. B., Fischer J. E. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet. 1976 Oct 23;2(7991):880–882. doi: 10.1016/s0140-6736(76)90541-9. [DOI] [PubMed] [Google Scholar]
  27. Unger R. H. Glucagon physiology and pathophysiology. N Engl J Med. 1971 Aug 19;285(8):443–449. doi: 10.1056/NEJM197108192850806. [DOI] [PubMed] [Google Scholar]
  28. Valverde I., Villanueva M. L. Heterogeneity of plasma immunoreactive glucagon. Metabolism. 1976 Nov;25(11 Suppl 1):1393–1395. doi: 10.1016/s0026-0495(76)80149-7. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES